Commonwealth Equity Services LLC Sells 2,450 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Commonwealth Equity Services LLC trimmed its position in shares of Schrödinger, Inc. (NASDAQ:SDGR – Get Rating) by 3.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 76,848 shares of the company’s stock after selling 2,450 shares during the period. Commonwealth Equity Services LLC owned 0.11% of Schrödinger worth $1,919,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Woodline Partners LP increased its holdings in Schrödinger by 425.0% in the 2nd quarter. Woodline Partners LP now owns 571,126 shares of the company’s stock worth $15,083,000 after acquiring an additional 462,345 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Schrödinger by 44.2% in the second quarter. JPMorgan Chase & Co. now owns 435,064 shares of the company’s stock worth $11,490,000 after purchasing an additional 133,277 shares in the last quarter. Stephens Investment Management Group LLC raised its position in shares of Schrödinger by 7.6% in the third quarter. Stephens Investment Management Group LLC now owns 776,532 shares of the company’s stock valued at $19,398,000 after purchasing an additional 54,683 shares during the period. Lazard Asset Management LLC lifted its stake in shares of Schrödinger by 4.1% during the 3rd quarter. Lazard Asset Management LLC now owns 645,861 shares of the company’s stock valued at $16,133,000 after buying an additional 25,550 shares in the last quarter. Finally, Greenwood Capital Associates LLC boosted its holdings in Schrödinger by 9.1% in the 3rd quarter. Greenwood Capital Associates LLC now owns 18,982 shares of the company’s stock worth $474,000 after buying an additional 1,577 shares during the period. 68.70% of the stock is owned by hedge funds and other institutional investors.

Schrödinger Trading Up 3.6 %

SDGR stock opened at $24.32 on Tuesday. The company’s 50 day moving average is $23.24 and its 200 day moving average is $22.67. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of -11.58 and a beta of 1.02. Schrödinger, Inc. has a 1-year low of $15.85 and a 1-year high of $37.25.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SDGR shares. Citigroup increased their target price on Schrödinger from $48.00 to $51.00 and gave the stock a “buy” rating in a research report on Tuesday, January 31st. The Goldman Sachs Group started coverage on Schrödinger in a report on Monday, December 19th. They set a “neutral” rating and a $23.00 target price for the company. Morgan Stanley increased their price target on shares of Schrödinger from $38.00 to $39.00 and gave the stock an “equal weight” rating in a report on Friday. BMO Capital Markets reduced their price objective on shares of Schrödinger from $83.00 to $78.00 and set an “outperform” rating for the company in a research note on Wednesday, March 1st. Finally, Piper Sandler increased their target price on shares of Schrödinger from $86.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, January 19th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Schrödinger currently has a consensus rating of “Moderate Buy” and a consensus target price of $55.60.

Insiders Place Their Bets

In other news, CEO Ramy Farid sold 66,886 shares of the firm’s stock in a transaction on Wednesday, January 4th. The shares were sold at an average price of $18.28, for a total transaction of $1,222,676.08. Following the sale, the chief executive officer now owns 184,432 shares in the company, valued at approximately $3,371,416.96. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 5.90% of the company’s stock.

About Schrödinger

(Get Rating)

Schrödinger, Inc, together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.